Premenstrual syndrome in France: Epidemiology and therapeutic activity of 1000 mg of micronized purified flavonoid fraction in 1473 gynecological out-patients;Le syndrome premenstruel en France: Epidemiologie et activite therapeutique de 1000 mg de fraction flavonoique purifiee micronisee chez 1473 femmes consultant en gynecologie

Contraception Fertilite Sexualite

Volumn 25, Issue 1, 1997, Pages 85-90

  Serfaty, D ^a   Magneron, A C ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

epidemiology; phlebotropic treatment; premenstrual syndrome

Indexed keywords

DAFLON; FLAVONOID; DIOSMIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PREMENSTRUAL SYNDROME; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; DIOSMIN; FEMALE; FRANCE; HUMANS; PREMENSTRUAL SYNDROME; TREATMENT OUTCOME;

EID: 0030638910     PISSN: 11578181     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)